Biosynthesis technology making strong advances Two promising pipeline candidates Inclusion in the CSE25 Index InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids (http://cnw.fm/uIL78). The company recently announced it has enabled the production of all four “gateway” cannabinoids using genetically engineered microorganisms. … Continue reading “InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) Biosynthesis Technology Demonstrates Robust Diversity”
EVIO, Inc. (OTCQB: EVIO), through its EVIO Labs division, is a national leader in providing accredited analytical testing, scientific research and advisory services to the regulated cannabis industry and provides state-mandated ancillary services required for ensuring the safety and quality of the cannabis supply in the United States. During the past two years, EVIO Labs … Continue reading “CannabisNewsBreaks – Why Cannabis Market Investors are Keeping an Eye on EVIO, Inc. (EVIO)”
Forbes predicts medical marijuana sales to reach $13.3 billion by 2020 Biotech/pharma market could surpass $20 billion by 2020, per estimates from Viridian Capital Advisors InMed’s biosynthesis process uses DNA and E. coli to produce cannabinoids that are identical to the 90+ found in nature The company’s pipeline drugs, focusing on rare dermatological diseases, glaucoma … Continue reading “InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Paving the Way as Biosynthesis Promises to Revolutionize Drug Development”
Name change to EVIO, Inc., from Signal Bay, Inc., reflects fact that EVIO Labs division generates majority of company volume New ticker symbol of EVIO will become effective October 3, 2017, for the legalized cannabis industry’s quality control testing and ancillary advisory services company Reverse stock split is positioned to attract institutional investors to provide … Continue reading “EVIO, Inc. (SGBYD) Changes Name, Adopts New Ticker Symbol and Announces a Reverse Stock Split”
NASDAQ Biotechnology Index up and climbing Developing new treatment for acute myeloid leukemia (AML) Lead candidate, Annamycin, now at phase II Since a rising sea lifts all boats, it’s decidedly good news for Moleculin Biotech, Inc. (NASDAQ: MBRX) that the NASDAQ Biotechnology Index (NBI) is enjoying a spring tide. The index has offered a year-to-date … Continue reading “Moleculin Biotech (NASDAQ: MBRX) to Begin Preparing Clinical Testing Sites for Leukemia Treatment”
Shares of Moleculin Biotech (NASDAQ: MBRX) rose 7% this morning on news that the company has selected Bioscience SA, a Polish contract research organization (CRO), to begin identifying and preparing clinical testing sites in Poland for Annamycin. The company’s drug candidate, Annamycin, is being evaluated for the treatment of relapsed or refractory acute myeloid leukemia … Continue reading “CannabisNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Selects Bioscience SA as Polish CRO”
Despite the fire-breathing from Attorney-General Jefferson Beauregard Sessions III, there is a distinct feeling that marijuana has entered the mainstream now that Goldman Sachs has initiated coverage on GW Pharma (NASDAQ: GWPH). GW Pharma is the biopharmaceutical that developed the cannabinoid-derived Sativex to treat spasticity due to multiple sclerosis (MS), now approved by regulatory authorities … Continue reading “InMed Pharmaceuticals, Inc. (IMLFF) is a Player in the Billion Dollar Cannabis Biotech Market”
Late February, a study was released (http://nnw.fm/R2CEp) reviewing evidence that supports the use of cannabinoids to treat Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Also known as Lou Gehrig’s disease, ALS is a fatal illness that attacks the nerve cells that control voluntary … Continue reading “ChineseInvestors.com (CIIX) Helping Treat Patients with Amyotrophic Lateral Sclerosis”
The following is the FULL CannabisNewsWire Release Distribution List. The National Newsline Wire Press Release is distributed to newspapers, broadcast outlets, newswires, websites, online databases and relevant industry trade publications. Distribution methods include real−time, full−text feeds via the AP satellite network, Internet FTP and content syndicates, as well as personalized email newsletters. Top 1-10 A-B … Continue reading “National Wire Press Release Distribution Points A-B”
The following is the FULL CannabisNewsWire Release Distribution List. The National Newsline Wire Press Release is distributed to newspapers, broadcast outlets, newswires, websites, online databases and relevant industry trade publications. Distribution methods include real−time, full−text feeds via the AP satellite network, Internet FTP and content syndicates, as well as personalized email newsletters. Top 1-10 A-B … Continue reading “National Wire Press Release Distribution Points S-T”
